COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,544 Articles (22,881 medRxiv, 8,663 bioRxiv)

Most recent first Previous |  Page 1789: Articles 17881-17890  | Next

Mice immunized with the vaccine candidate HexaPro spike produce neutralizing antibodies against SARS-CoV-2
Seephetdee, C., Buasri, N., Bhukhai, K., Srisanga, K., Manopwisedjaroen, S., Lertjintanakit, S., Phueakphud, N., Pakiranay, C., Kangwanrangsan, N., Srichatrapimuk, S., Sungkanuparph, S., Kirdlarp, S., Chutipongtanate, S., Thitithanyanont, A., Hongeng, S., Wongtrakoongate, P.
10.1101/2021.02.27.433054 — Posted: 2021-03-01
A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19).
Rajczewski, A. T., Mehta, S., Ngyuen, D. D. A., Grüning, B. A., Johnson, J. E., McGowan, T. F., Griffin, T., Jagtap, P.
10.1101/2021.02.09.21251427 — Posted: 2021-03-01
Evaluating the trade-off between transmissibility and virulence of SARS-CoV-2 by mathematical modeling
Yang, H. M., Lombardi Junior, L. P. P., Yang, A. C.
10.1101/2021.02.27.21252592 — Posted: 2021-03-01
Modeling infection dynamics and mitigation strategies to support K-6 in-person instruction during the COVID-19 pandemic
Morrison, D. E., Nianogo, R., Manuel, V., Arah, O. A., Anderson, N., Kuo, T., Inkelas, M.
10.1101/2021.02.27.21252535 — Posted: 2021-03-01
Estimating the burden of post-COVID-19 syndrome in a population-based cohort study of SARS-CoV-2 infected individuals: Implications for healthcare service planning
Menges, D., Ballouz, T., Anagnostopoulos, A., Aschmann, H. E., Domenghino, A., Fehr, J. S., Puhan, M. A.
10.1101/2021.02.27.21252572 — Posted: 2021-03-01
FRONTLINE COMMUNITIES AND SARS-COV-2-MULTI-POPULATION MODELING WITH AN ASSESSMENT OF DISPARITY BY RACE/ETHNICITY USING ENSEMBLE DATA ASSIMILATION
Fleurantin, E., Sampson, C., Mase, D., Bennett, J., Fernandes Nunez, T., Marx, S., Evensen, G.
10.1101/2021.02.27.21252589 — Posted: 2021-03-01
The accuracy of novel antigen rapid diagnostics for SARS-CoV-2: a living systematic review and meta-analysis.
Bruemmer, L. E., Katzenschlager, S., Gaeddert, M., Erdmann, C., Schmitz, S., Bota, M., Grilli, M., Larmann, J., Weigand, M. A., Pollock, N., Carmona, S., Ongarello, S., Sacks, J., Denkinger, C. M.
10.1101/2021.02.26.21252546 — Posted: 2021-03-01 Discussion: Onsite
Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19
Peluso, M. J., Deitchman, A. N., Torres, L., Iyer, N. S., Nixon, C. C., Munter, S. E., Donatelli, J., Thanh, C., Takahashi, S., Hakim, J., Turcios, K., Janson, O., Hoh, R., Tai, V., Hernandez, Y., Fehrman, E. A., Spinelli, M. A., Gandhi, M., Trinh, L., Wrin, T., Petroploulos, C. J., Aweeka, F. T., Rodriguez-Barraquer, I., Kelly, J. D., Martin, J. N., Deeks, S. G., Greenhouse, B., Rutishauser, R. L., Henrich, T. J.
10.1101/2021.02.26.21252308 — Posted: 2021-03-01
REACT-2 Round 5: increasing prevalence of SARS-CoV-2 antibodies demonstrate impact of the second wave and of vaccine roll-out in England
Ward, H., Cooke, G., Whitaker, M., Redd, R., Eales, O., Brown, J., Collet, K., Cooper, E., Anna, D., Kathryn, J., Maya, M., Willicombe, M., Day, S., Atchison, C., Darzi, A., Donnelly, C. A., Riley, S., Ashby, D., Barclay, W. S., Elliott, P.
10.1101/2021.02.26.21252512 — Posted: 2021-03-01 Discussion: Onsite
Povidone iodine, hydrogen peroxide and chlorhexidine mouthwashes reduce SARS-CoV2 burden in whole mouth fluid and respiratory droplets
Jayaraman, B. G., Rajan, G., Kannian, P., Lavanya, C., Ravichandran, K., Kumarasamy, N., Ranganathan, K., Ashwini, V., Mahanathi, P., Challacombe, S. J., Webster-Cyriaque, J., Johnson, N. W.
10.1101/2021.02.25.21252488 — Posted: 2021-03-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).